Ana Lizet Morales-Ubaldo

Dr. Ana Lizet Morales-Ubaldo

Universidad Autónoma del Estado de Hidalgo, Pachuca, Hidalgo, Mexico
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2021 in Agronomy
Verified
Journal Article
Open access
PDF file
Ana Lizet Morales-UbaldoAna Lizet Morales-Ubaldo
Ana Lizet Morales-Ubaldo
Nallely Rivero-PerezNallely Rivero-Perez
Nallely Rivero-Perez
FAFidel Avila-Ramos
Fidel Avila-Ramos
EAEliazar Aquino-Torres
Eliazar Aquino-Torres
JPJudith Prieto-Méndez
Judith Prieto-Méndez
Adrian Zaragoza-BastidaAdrian Zaragoza-Bastida
Adrian Zaragoza-Bastida
Due to the emergence of bacterial resistance in phytopathogenic microorganisms, it is necessary to search for new treatment alternatives for these pathogens. Natural extracts are a potential source of bioactive compounds that can act against such bacterial strains. The antibacterial activity of Larrea tridentata against bacteria with public health importance has been documented; however, few reports cover pathogens associated with the agricultural sector. The aim of the present study was to evaluate the antibacterial activity of Larrea tridentata hydroalcoholic extract (LTHE) and fractions against phytopathogenic bacteria. LTHE was obtained by the maceration technique and then subjected to bipartition using solvents of different polarities. Clavibacter michiganensis sbsp. michiganensis, Pseudomonas syringae, and Xanthomonas campestris strains were used, and their antibiotic sensitivity was determined. The minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of LTHE and its fractions (aqueous: LTAq-F; organic: LTEtOAc-F) were determined. LTHE and its organic fraction showed bactericidal activity against the three bacteria, showing better activity against X. campestris, exhibiting an MIC of 0.39 mg/mL and an MBC of 0.78 mg/mL. The results show that LTHE and its organic fraction have bactericidal activity in vitro against Clavibacter michiganensis sbsp. michiganensis, Pseudomonas syringae, and Xanthomonas campestris.

24 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Ana Lizet Morales-UbaldoAna Lizet Morales-Ubaldo
Ana Lizet Morales-Ubaldo
Nallely Rivero-PerezNallely Rivero-Perez
Nallely Rivero-Perez
BVBenjamin Valladares-Carranza
Benjamin Valladares-Carranza
AMAlfredo Madariaga
Alfredo Madariaga
RHRosa Isabel Higuera-Piedrahita
Rosa Isabel Higuera-Piedrahita
Adrian Zaragoza-BastidaAdrian Zaragoza-Bastida
Adrian Zaragoza-Bastida
For centuries, traditional medicine from plants (phytotherapy) was the only treatment for infectious and non-infectious diseases. Although it is still practiced in several countries with excellent therapeutic results, it is frequently underestimated because, unlike Western medicine, it is not based on an empirical scientific foundation. However, interest in the search for plant-based therapeutic resources has been stimulated by disciplines such as phytochemistry and the side effects of conventional pharmacological therapies. For example, Larrea tridentata is a perennial shrub used in traditional medicine in northern Mexico and the southern United States to treat infertility, rheumatism, arthritis, colds, diarrhea, skin problems, pain, inflammation and excess body weight. Scientific research has revealed its beneficial effects—antioxidant, antitumor, neuroprotective, regenerative, antibacterial, antiviral, antifungal, anthelmintic, antiprotozoal and insecticidal—although reports indicate that some compounds in Larrea tridentata may be hepatotoxic and nephrotoxic. Therefore, the aim of this review was to highlight the updates regarding phytochemical compounds and the pharmacological properties of Larrea tridentata.

29 August 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
Nallely Rivero-PerezNallely Rivero-Perez
Nallely Rivero-Perez
JHJerelly L. Hernández-Alvarado
Jerelly L. Hernández-Alvarado
BVBenjamín Valladares-Carranza
Benjamín Valladares-Carranza
LDLucía Delgadillo-Ruiz
Lucía Delgadillo-Ruiz
Deyanira Ojeda-RamírezDeyanira Ojeda-Ramírez
Deyanira Ojeda-Ramírez
Adrian Zaragoza-BastidaAdrian Zaragoza-Bastida
Adrian Zaragoza-Bastida
Coccidiosis in rabbit production is responsible for high morbidity, mortality, and economic losses. The use of natural antimicrobial substances in rabbits represents a promising way to improve their health and production. The aim of the present study was to assess the activity of Salix babylonica hydroalcoholic extract (SBHE) on the elimination of Eimeria spp. in rabbits. The phytochemical compounds and chemical composition of SBHE were determined. The cytotoxicity of SBHE was determined by a microwell assay using Artemia salina. Twenty-five New Zealand rabbits, 28 days old and 872 ± 171 g body weight (BW), were used in a completely randomized design. The rabbits were assigned to five groups of five rabbits, control group (A) received only basal diet (BD), B group received BD + 25 mg/kg BW of SBHE, C group received BD + 50 mg/kg BW of SBHE, D group received BD + 100 mg/kg BW of SBHE, and E group received BD + coccidiostat Baycox® (75 mg/kg body weight) for 28 days. Feces samples were collected at days 0, 7, 14, 21, and 28; morphological and morphometric identifications of Eimeria were carried out by the flotation technique and counting of oocysts by the McMaster technique. The rabbits were found naturally infected with Eimeria spp. The SBHE present phytochemicals with anticoccidial activity, and the cytotoxicity test indicate that this extract is nontoxic. This study demonstrates that oral administration of SBHE at 25 and 50 mg/kg BW reduced the release of oocysts per gram of feces. This effect was observed at day 14 and had the most significant effect at day 28 for both concentrations. The results indicate that SBHE could be a natural alternative for the control of coccidiosis in rabbit production.

5 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Ana Lizet Morales-UbaldoAna Lizet Morales-Ubaldo
Ana Lizet Morales-Ubaldo
Manasés Gonzalez-CortazarManasés Gonzalez-Cortazar
Manasés Gonzalez-Cortazar
Adrian Zaragoza-BastidaAdrian Zaragoza-Bastida
Adrian Zaragoza-Bastida
MMMartín A. Meza-Nieto
Martín A. Meza-Nieto
BVBenjamin Valladares-Carranza
Benjamin Valladares-Carranza
Nallely Rivero-PerezNallely Rivero-Perez
Nallely Rivero-Perez
Bovine mastitis is one of the most common diseases in dairy cows, and it causes significant economic losses in dairy industries worldwide. Gram-positive and Gram-negative bacteria can cause bovine mastitis, and many of them have developed antimicrobial resistance. There is an urgent need for novel therapeutic options to treat the disease. Larrea tridentata-derived compounds represent an important potential alternative treatment. The aim of the present study was to isolate and characterize antibacterial compounds from Larrea tridentata against multidrug-resistant bacteria associated with bovine mastitis. The L. tridentata hydroalcoholic extract (LTHE) exhibited antibacterial activity. The extract was subjected to a bipartition, giving an aqueous fraction (moderate antibacterial activity) and an organic fraction (higher antibacterial activity). Chromatographic separation of the organic fraction enabled us to obtain four active sub-fractions. Chemical analyses through HPLC techniques were conducted for the LTHE, fractions, and sub-fraction Ltc1-F3, from which we isolated two compounds, characterized by 1H and 13C NMR analyses. Compound nor-3 demethoxyisoguaiacin exhibited the best antibacterial activity against the evaluated bacteria (MIC: 0.01–3.12 mg/mL; MBC: 0.02–3.12 mg/mL). The results indicated that nor-3 demethoxyisoguaiacin can be used as an alternative treatment for multidrug-resistant bacteria associated with mastitis.

1 July 2020 in Revista de Salud Pública
Verified
Journal Article
Open access
PDF file
JYJosé E Yescas-Benítez
José E Yescas-Benítez
Nallely Rivero-PerezNallely Rivero-Perez
Nallely Rivero-Perez
HMHugo Montiel-Díaz
Hugo Montiel-Díaz
BVBenjamin Valladares-Carranza
Benjamin Valladares-Carranza
APArmando Peláez-Acero
Armando Peláez-Acero
Adrian Zaragoza-BastidaAdrian Zaragoza-Bastida
Adrian Zaragoza-Bastida
Objetivo Determinar el comportamiento temporal y espacial de la leptospirosis en México durante el periodo 2013-2019.Materiales y Métodos Se utilizó la información depositada en los boletines epidemiológicos del Sistema Nacional de Vigilancia Epidemiológica de México. Para determinar el comportamiento espacial se construyeron canales endémicos y análisis de series de tiempo. Para determinar el comportamiento espacial, se utilizó el modelo estadístico espacial Scan.Resultados Se determinó que los casos de leptospirosis en México se presentan todo el año; sin embargo, los picos endémicos se observaron en los meses de agosto, septiembre y octubre. Con respecto al comportamiento espacial, no se determinó ninguna agrupación estadísticamente; no obstante, los estados con la mayor prevalencia fueron: Sinaloa, con 146.7 casos por cada millón de habitantes, y Tabasco, con 142 casos por cada millón de habitantes.Discusión La leptospirosis es una enfermedad influenciada por los hábitos y las costumbres de la población, al igual que por variables climatológicas que favorecen el contacto con el agente etiológico. Esto coincide con lo reportado por otros estudios que han determinado que la incidencia de leptospirosis aumenta durante la época de lluvia y que esta enfermedad se relaciona con actividades de recreación en zonas tropicales.Conclusiones La leptospirosis es una enfermedad zoonótica emergente de gran importancia en México, que se presenta con mayor frecuencia en época de lluvias. Los estados de Sinaloa y Tabasco son los más afectados.

11 February 2020 in Animals
Verified
Journal Article
Open access
PDF file
Adrian Zaragoza-BastidaAdrian Zaragoza-Bastida
Adrian Zaragoza-Bastida
SAUDY CONSEPCION FLORES-AGUILARSAUDY CONSEPCION FLORES-AGUILAR
SAUDY CONSEPCION FLORES-AGUILAR
LALiliana Mireya Aguilar-Castro
Liliana Mireya Aguilar-Castro
Ana Lizet Morales-UbaldoAna Lizet Morales-Ubaldo
Ana Lizet Morales-Ubaldo
BVBenjamin Valladares-Carranza
Benjamin Valladares-Carranza
Nallely Rivero-PerezNallely Rivero-Perez
Nallely Rivero-Perez
Rattlesnakes have venoms with a complex toxin mixture comprised of polypeptides and proteins. Previous studies have shown that some of these polypeptides are of high value for the development of new medical treatments. The aim of the present study is to evaluate, in vitro, the antibacterial and hemolytic activity of Crotalus triseriatus and Crotalus ravus venoms. A direct field search was conducted to obtain Crotalus triseriatus and Crotalus ravus venom samples. These were evaluated to determine their antibacterial activity against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa through the techniques of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC). Hemolytic activity was also determined. Antibacterial activity was determined for treatments (Crotalus triseriatus 2) CT2 and (Crotalus ravus 3) CR3, obtaining a Minimum Inhibitory Concentration of 50 µg/mL and a Minimum Bactericidal Concentration of 100 µg/mL against Pseudomonas aeruginosa. CT1 (Crotalus triseriatus 1), CT2, and CR3 presented hemolytic activity; on the other hand, Crotalus ravus 4 (CR4) did not show hemolytic activity. The results of the present study indicate for the first time that Crotalus triseriatus and Crotalus ravus venoms contain some bioactive compounds with bactericidal activity against Pseudomonas aeruginosa which could be used as alternative treatment in diseases caused by this pathogenic bacterium.